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Abstract
Background: Endothelial dysfunction is a hallmark of diabetes mellitus and systemic arterial hypertension (SAH)
and an early maker for atherosclerosis. Aerobic exercise training is known to enhance endothelial function, but little
is understood about the effects of resistance or combined exercise training on endothelial function. The aim of this
study is to investigate the effect of a 12-week aerobic (AT), resistance (RT), or combined (aerobic and resistance, CT)
training program on endothelial function and assess associated effects on blood pressure in individuals with SAH.
Methods/design: Eighty-one subjects with SAH aged 18 to 70 years will be selected and randomly assigned to
three types of exercise training: AT, RT or CT. The study will involve the following procedures and tests: anamnesis,
anthropometric assessment, echocardiography, blood pressure measurements through ambulatory blood pressure
monitoring, flow-mediated dilation, ergospirometry, one repetition maximum test (1-RM), and blood collection
(number of circulating endothelial progenitor cells, number of circulating endothelial microparticles, lipid profile,
glucose, glycated hemoglobin, and creatinine). The AT intervention will consist of a 40-min exercise session with
progressive intensities ranging from 50 to 75 % of heart rate reserve. The RT intervention will consist of a 40-minute
session with four sets of six to 12 repetitions with a rest period of 60 to 90 seconds between each set and each
type of exercise. Weight loads will be adjusted to 60 to 80 % of 1-RM for six types of exercise. The CT intervention
will consist of a 20-min aerobic exercise session, followed by an additional 20-min resistance exercise session; each
resistance exercise will have two sets less to match the total training volume.
Discussion: The study results are expected evidence of cardiovascular protective effects of different types of
exercise training through the modulation of endothelial function in hypertensive individuals. Knowing the
magnitude of improvement of endothelium-dependent vasodilation for the different types of exercise training can
provide scientific evidence for the prescription of exercise programs for vascular protection targeting hypertensive
individuals.
Trial registration: The Brazilian Clinical Trials Registry (http://www.ensaiosclinicos.gov.br/) under RBR-9ygmdn and
dated 1 March 2015.
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Background
Cardiovascular diseases are largely determined by multi-
factorial risk factors that tend to interact and may be
present over the course of an individual’s lifetime. Obes-
ity [1, 2], physical inactivity [3, 4], and insulin resistance
[5] are all risk factors closely associated with systemic ar-
terial hypertension (SAH) and diabetes mellitus type 2.
In addition to these risk factors, smoking [6] and excess
weight [7] contribute to endothelial dysfunction [8, 9],
which is a hallmark of diabetes mellitus [10] and SAH
[11] and an early maker for atherosclerosis [12].
The endothelium is a single layer of cells that lines the
tunica intima of blood vessels [13] and plays a major
role in the modulation of vascular angiogenesis, inflam-
matory responses, and vascular tone and permeability
[14]. Vascular protection is particularly attributable to
endothelial nitric oxide synthase (eNOS), an enzyme in-
volved in the production of nitric oxide (NO).
The balance between endothelial injury and recovery
is critical to continuously maintaining endothelial func-
tion [15]. The bone marrow releases a progenitor cell
subtype called endothelial progenitor cells (EPCs), which
have the ability to migrate to the peripheral circulation
and differentiate into mature endothelial cells to main-
tain vascular integrity [16]. EPC levels have been associ-
ated with cardiovascular risk factors [17], endothelium-
dependent vasodilation [18], and clinical outcomes, in-
cluding hospitalization and cardiovascular death rates
[19]. In patients with cardiovascular risk factors such as
SAH [20], smoking [21], metabolic syndrome [22] and
diabetes mellitus [23], circulating levels of EPCs can be
reduced compared with healthy individuals of matching
age and sex. Endothelial dysfunction has been associated
with a decreased number and impaired function of EPCs
in patients with SAH, diabetes mellitus, and metabolic
syndrome, and thus an increased risk of atherosclerosis
would be expected [24].
On the other hand, regular exercise, also known as exer-
cise training, produces effects on the cardiovascular sys-
tem and has been proven to restore endothelial function
even in the presence of cardiovascular disease [25]. Regu-
lar exercise promotes changes in cholesterol levels and its
subfractions; accelerates the removal of chylomicrons and
low-density lipoproteins from circulation; increases the re-
lease of NO that seems to generate increased expression
of eNOS [26]; increases the number of circulating EPCs in
healthy individuals [27], as well as in individuals with
established cardiovascular disease [28]; and improves
plasma glucose [29], which has a direct link to impaired
endothelial function [30]. This assumption is consistent
with findings in healthy individuals [31], individuals with
diabetes mellitus type 2 [32], and patients with cardiovas-
cular conditions [33], showing that exercise training im-
proved vascular function and overall health.
Evidence with clinical relevance exists on the impact
of aerobic exercise on BP and blood glucose levels, but
no consensus exists regarding the effects of resistance
training and even less evidence is available on combined
training (resistance and aerobic) and the regulatory
mechanisms of endothelial function and its relationship
with BP in hypertensive individuals. Thus, despite
present evidence showing the benefits of exercise and
physical training on blood pressure [34] and blood glu-
cose levels [35], more studies are needed to investigate
further the mechanisms involved with endothelial func-
tion especially their relationship with blood pressure
reduction.
The objective of this study is to evaluate the chronic
effects of exercise training on endothelial function
modulation in hypertensive patients undergoing a 12-
week exercise intervention of aerobic, resistance, or
combined (aerobic and resistance) training. Modulation
of endothelial function will be assessed by flow-mediated
dilation (FMD) [36] and biochemical [37] and cellular
parameters [38, 39]. The primary and secondary study
objectives are listed in Tables 1 and 2, respectively.
Methods/design
The study will be coordinated at the Fundação Universi-
tária de Cardiologia (FUC) Health Sciences Graduate
Program together with the Instituto de Cardiologia (IC)
in the city of Porto Alegre, Rio Grande do Sul, Brazil.
Study design
A randomized controlled and evaluator-blinded clinical
trial will be conducted as shown in Fig. 1.
Sample selection
The study sample will comprise individuals with no his-
tory of cardiovascular disease (except for SAH controlled
with the use of medications), neuromuscular, endocrine,
and/or metabolic conditions (except for diabetes mellitus
type 2) who are attending the IC health care facilities.
Subjects will be selected based on information col-
lected from their medical records. Eligible individuals
will be contacted by telephone and informed of the pur-
pose and procedures of the study. For those willing to
participate, a first visit will be scheduled when a clinical
questionnaire will be administered, and they will be
asked to sign a free informed consent form to participate
in the study. Other study visits will be scheduled for
Table 1 Primary objectives of the study
• To investigate the effects of AT, RT and CT on flow-mediated vasodilation
of the brachial artery in hypertensive individuals
• To assess the impact of different types of training (AT, RT, and CT) on the
number of circulating endothelial progenitor cells and number of circulating
endothelial microparticles in hypertensive individuals
AT, aerobic training; RT, resistance training; CT, concurrent training
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those meeting the inclusion criteria of the study
(Table 3).
The following formula will be used for the calculation
of sample size (np) to estimate the number of hyperten-
sive individuals to be included in the study:
μp
 





where, npo = sample size at time point zero, s
2 = variance
of the sampling distribution, and tα;gl = sampling distri-
bution according to a predetermined error probability
(P ≤ 0.05) and degrees of freedom for npo.
The mean incidence rate of SAH in Brazil is 20 % of the
population [40]. Considering the baseline value (n0 = 30);
tα;gl = t0.05;29 = 2.045; s
2 = 0.05 (based on the maximum
value of the coefficient of variation of endothelial vasodila-
tion); and the maximum error of the estimate taken as the
maximum variability in arterial diameter measures by two
observers (0.02 %) [41], it was estimated that np1 = 26.1 ≅
26 hypertensive individuals. Thus, in the estimate of n, the
approximation used considered np1 = 26, gl = 23, and
t0.05;23 = 2.069. The np1 = 26.8 ≅ 27. The estimate of the
sample size for the study was n = 80.3 ≅ 81 hypertensive
individuals who will be randomly assigned to the three
training interventions.
Randomization procedure
A randomization for the proposed interventions will be
generated by a computer program (www.randomizatio-
n.org) including the distribution coded at a 1:1 ratio.
The random assignment of subjects to training interven-
tion groups will be into three blocks of 27. Subjects will
be drawn up to 27 in each intervention group: aerobic
training (AT), resistance training (RT), and combined
training (CT, resistance and aerobic). All subjects will be
blinded to intervention allocation and will have access to
this information only after the baseline assessment. All
evaluators of the study subjects will be also blinded to
intervention allocation.
Baseline assessment of subjects
After recruitment, the subjects will undergo baseline as-
sessment to collect information on their main character-
istics before intervention. A descriptive exploratory
questionnaire will be administered to collect information
on i) demographic and socioeconomic variables (gender,
age, socioeconomic status, education, skin color and
marital status); ii) behavioral variables (physical activity
measured by the International Physical Activity Ques-
tionnaire (www.ipaq.ki.se), smoking status, and alcohol
consumption); iii) anthropometric variables (body
weight, height, and waist circumference); iv) clinical vari-
ables (BP and use of antihypertensive medication); and
v) quality of life assessed by the Medical Outcomes
Study 36-Item Short Form Health Survey (SF-36) [42].
Eligible individuals who are willing to participate will be
instructed to fast for 8 h and come for a scheduled sec-
ond visit at the study site. In this visit, subjects will have
blood samples collected for blood testing, in addition to
the assessment of FMD of the brachial artery and ambu-
latory blood pressure monitoring (ABPM) cuff place-
ment. A snack will be offered at the end of this visit. In
the third visit, the ABPM cuff will be removed and sub-
jects will undergo physical fitness tests (VO2max). In the
fourth visit, 1-RM testing will be conducted. Subjects
who did not show up for the scheduled visits will be
contacted again. All blood samples will be collected by a
nurse technician. All assessment procedures will be su-




Blood collection and testing will be performed at the
ICFUC. Subjects’ blood will be collected after a fast of
8 h. The blood sample will be tested for biochemical
screening (lipid profile, glucose, glycated hemoglobin,
and creatinine), number of EPCs and number of circu-
lating endothelial microparticles. In addition, blood rhe-
ology will be assessed for potential changes in the
sample studied including increased blood viscosity, re-
duced red blood cell (RBC) deformability, increased
RBC aggregation, fibrinogen levels, and erythrocyte sedi-
mentation rate (ESR).
Progenitor cell and endothelial progenitor cell count
A 15-ml blood sample for the EPCs will be collected in a
Sodium Heparin Vacutainer™ tube. Peripheral blood mono-
nuclear cells (PBMC) will be isolated using Ficoll-Paque
(GE Heathcare Life Sciences, Uppsala, Sweden). Progenitor
cells (PCs) will be defined as CD34+/CD45dim, and EPCs
as CD34+/KDR+/CD45dim. Briefly, blood samples will be
diluted once with phosphate buffered saline (PBS) and lay-
ered onto Ficoll-Paque in 15-ml conical tubes (BD
Table 2 Secondary objectives of the study
To assess the effectiveness of different types of training (AT, RT and CT)
regarding the following:
• Blood pressure levels: clinical assessment and ABPM
• Serum levels of total cholesterol, HDL, LDL and triglycerides
• Fasting blood glucose and glycated hemoglobin
• Blood viscosity, RBC deformability, RBC aggregation, fibrinogen levels
and ESR
• Echocardiography for determination of heart chamber sizes and wall
thickness
• Functional capacity through maximum oxygen consumption (VO2max)
• 1-RM
• Abdominal obesity and BMI
ABPM, ambulatory blood pressure monitoring; AT, aerobic training; RT,
resistance training; CT, concurrent training; HDL, high-density cholesterol; LDL,
low-density cholesterol; RBC red blood cell; ESR, erythrocyte sedimentation
rate; 1-RM, one-repetition maximum strength test; BMI, body mass index.
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Biosciences, San Jose, CA, USA). Each tube will be cen-
trifuged at 400 xg for 30 min (Eppendorf-5810, Ham-
burg, Germany), and the PBMCs at the interface will
be collected. Cells will be washed once with RPMI-
1640 medium (Gibco™, Vancouver, Canada); stained
with 5 μl of antihuman-CD45 FITC, 5 μl of
antihuman-CD34 PE (clone 6G12), and 8 ul of
antihuman-KDR-Alexa Fluor 647 (BD Biosciences,
Fig. 1 Study design. Flow chart of how the clinical trial will be conducted
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San Jose CA, USA); and incubated in the dark for
30 min, followed by the addition of 500 μl of PBS
until resuspension and acquisition in a flow cytometer
(FACSCalibur, CellQuest software, BD Biosciences,
San Diego, CA, USA). The total number of events re-
corded on the mononuclear cells gate was 200,000.
The percentage of CD34+ cells was calculated based
on the measured number of leukocytes (CD45+ cells)
using the ISHAGE (International Society for Hema-
totherapy and Graft Engineering) gating strategy [43].
Circulating endothelial microparticles count
A 5-ml blood sample for circulating endothelial micro-
particles will be collected in a Citrate Vacutainer™ tube.
These samples will be analyzed for CD31+/CD41- and
CD144+. Initially, the blood will be rendered to separate
the platelet-rich plasma and the platelet-poor plasma.
All blood samples will be subjected to a two-step proto-
col centrifugation (860 xg for 15 min at 4 °C, followed
by 1700 xg for 5 min at 20 °C) before being stored at
-80 °C. Phenotype analysis of the endothelial microparti-
cles will be subsequently performed on samples thawed
using a flow cytometer Fluorescence Activated Cell Ana-
lyser (FACScanto II da BD Biosciences, San Jose, CA,
USA) and the results analyzed with the BD FACS Diva
software (BD). For phenotyping of the endothelial mi-
croparticles, the following antibodies will be used: anti-
CD31+ PE, anti-CD41+ PC7, and anti-CD144+ PE.
Endothelial microparticles will be defined as elements
with size > 0.1 and < 1.0 μm and showing surface
markers CD31+/CD41- and CD144+ [44].
Assessment of flow-mediated dilation (FMD)
Endothelial function will be measured noninvasively by
using brachial artery ultrasound (EnVisor series, Philips
Ultrasound, Bothell, WA, USA). This assessment will be
performed with a 7 to 12 MHz linear transducer in a
heated room at 21 to 24 °C at ICFUC. A software pro-
gram will be used for two-dimensional color-Doppler
imaging acquisition with a simultaneously recorded elec-
trocardiogram (ECG). Image data will be recorded on a
DVD. To minimize operational errors, the subject’s arm,
and the ultrasound transducer will be positioned and
maintained in the same position during the procedure.
Baseline images will be recorded. A cuff will be placed
around the forearm and inflated to 50 mmHg above sys-
tolic pressure for at least 5 min and then removed. Lon-
gitudinal ultrasound images of the brachial artery walls
will be acquired to assess endothelium-dependent vaso-
dilation. The expected coefficient of variation between
the images will be 1.8 to 5.0 %. Flow-dependent vaso-
dilation responses will be expressed as the percentage
change in the brachial diameter [36].
Echocardiography
Echocardiography is a noninvasive imaging approach
that uses ultrasound to assess the structures and func-
tioning of the heart; it measures the chamber size and
mobility of the walls, valve structures, ejection fraction,
diastolic dysfunction parameters, and the direction and
speed of blood flowing through the heart chambers.
Medical personnel at ICFUC accredited by the Brazilian
Society of Echocardiography and blinded to intervention
allocation will perform transthoracic echocardiograms
with image acquisition in second-harmonic generation
with the use of ACUSON SC2000 equipment and a 3 to
12 MHz transducer (Siemens). This data will be digitally
stored for further analysis by more experienced
evaluators.
Blood pressure
Two different approaches will be used to evaluate the
BP levels: clinical assessment and ambulatory blood
pressure monitoring (AMBP). The clinical assessment
will consist of acute and subacute BP measurements as a
way to evaluate exercise responses. Measurements will
be taken with the subject in a sitting position using a
semi-automatic sphygmomanometer (Omron 705CP).
BP levels will be measured in both arms in the pre-study
assessments, and the arm with highest values will be
used for measurements in the study. Subacute clinical
assessments will be conducted at the following time
Table 3 Inclusion and exclusion criteria for the study
Inclusion criteria Exclusion criteria
• Males and females aged 18 to 70 years
• Diagnosed with SAH
• Signed a free informed consent form
• Considered insufficiently active (IPAQ)
• Non-active smokers
• Currently engaging in any type of systematic physical activity
• Blood pressure hyper-reactivity in the clinical assessment (SBP > 220 mmHg
and/or increase in DBP > 15 mmHg)
• Ongoing infectious diseases
• Obesity class II or III (BMI)
• Heart failure class III or IV; recent cardiovascular event (in the last three months); chronic
renal failure; and malignant disease with life expectancy < 2 years
• Orthopedic impairments or any physical or mental limitations that prevent physical exercises
• After the training intervention, individuals who attended < 85 % or missed > 2 consecutive
training sessions will be excluded from the sample. Subjects will be encouraged to complete
any missed session at the end of training by performing additional sessions.
SAH, systemic arterial hypertension; IPAQ, International Physical Activity Questionnaire; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index
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points: before the beginning of each training session
(pre-exercise), immediately after exercise (early post-
exercise), and 20 min after the end of each session (late
post-exercise). ABPM will be performed in all study
groups before the first exercise session and at the com-
pletion of the entire training intervention. Blood pres-
sure measurements will be obtained from an
oscillometric Dina-map™ device. Both assessments will
follow the VI Brazilian National Guidelines in Cardi-
ology [40].
Functional capacity
VO2max will be obtained from a cardiopulmonary exer-
cise test using a cycle ergometer and 12-lead ECG moni-
toring supervised by a cardiologist. Gas exchange
measurements will be taken with the use of an ergo spir-
ometer (VO2000 model, Inbramed, Porto Alegre, Brazil).
This device collects exhaled gas samples and can store
data acquired with each breath (breath-by-breath). Heart
rate will be monitored with a frequency meter (Polar
S610 model) as follows: online heart rate readings, deter-
mination of maximum heart rate at each exercise stage,
and stopwatch with partial times. The maximal exercise
test will be scheduled at least 48 h in advance. Upon
participant arrival at the study site, BP levels will be
measured according to the study protocol. Subjects will
be asked to sit on a chair, and a facemask (or nozzle)
and a frequency meter will be attached. Resting VO2 and
VCO2 measurements will be taken, and the test will be
started only when the respiratory exchange ratio (RER)
is lower than 0.95. The test will be stopped when the
subjects are exhausted and signal that they can no lon-
ger turn the pedals [45].
One-repetition maximum strength (1-RM) assessment
The one-repetition maximum strength test (1-RM) will
be used to measure the maximum strength. Subjects will
warm up on a cycle ergometer for 5 min. They will then
be instructed to perform the maximum number of repe-
titions with a given load until they can perform only one
lift of a load in up to five attempts to achieve the max-
imum load. A rest period of 3 to 5 min will be provided
between each attempt, so rest intervals are of sufficient
length to allow the restoration of energy reserves [46].
The same procedure will be followed for all types of
strength exercises proposed in the study (leg press,
bench press, knee extension, biceps curl, knee bend, and
low row). The speed of movements will be controlled
with a metronome in both intervention protocols. Exer-
cises will be performed at a pace of 2 seconds for both
concentric and eccentric phases. This test will take place
at three time points: during the first 2 weeks (60 % of 1-
RM); during the intermediate weeks (70 % of 1-RM);
and at the end of week 8 (80 % of 1-RM) to maintain
exercise at an appropriate intensity throughout the
protocol.
Intervention protocols
The study intervention will comprise 12 weeks of exer-
cise sessions, lasting on average 50 min, three times a
week. Exercise sessions will include a warm-up period of
5 to 10 min at the beginning, resistance or combined
aerobic exercises for 40 min, and a cool down/relaxation
period.
AT will be performed on a cycle ergometer for the en-
tire intervention. Subjects will be monitored with heart
rate monitors (Table 4).
RT will include six types of exercises that alternate
between large and small muscle groups (leg press, bench
press, knee extension, biceps curl, knee bend, and low
row) for the entire training intervention (Table 5).
CT will consist of resistance and aerobic exercises
combined in one session performed over a 40-min
period set as in the other two protocols, so that training
volume is similar across all intervention groups for the
entire intervention (Table 6).
A basic training principle is the progression of exercise
intensity, duration, or frequency. Progression of exercise
in the study intervention will be through gradual exer-
tion increase for the protocols [46]. Borg’s rating scale of
perceived exertion (6 to 20 point scale) will be used to
help control the training intensities [47]. All subjects will
be allowed an initial adjustment period. Those with rest-
ing BP levels higher than 160 mmHg (SBP) and/or
105 mmHg (DBP) before cardiopulmonary testing, 1-
RM, or an exercise session (AT, RT and CT) will not be
allowed to participate in any activities [40]. Those ex-
periencing BP higher than the recommended level on a
second occasion will be referred to the study cardiologist
for evaluation. The cardiologist will determine whether
the subject can continue participating in the study.
Subjects diagnosed with SAH and diabetes mellitus
type 2 will have their blood glucose checked (Optium
Xceed, Abbott Diabetes Care, Inc., Alameda, CA, USA)
in addition to BP measurements before cardiopulmonary
exercise testing, 1-RM or an exercise session (AT, RT,
and CT) and every 15 min throughout exercise sessions.
If the blood glucose levels are lower than 100 mg/dL
Table 4 Intensity and duration of aerobic training on a stationary
bike during a 12-week intervention
Phase I Phase II Phase III
Intensity 50 to 65 %
HRR
55 to 70 %
HRR
60 to 75 %
HRR




HRR, heart rate reserve
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during cardiopulmonary exercise testing, 1-RM, or exer-
cise sessions (AT, RT and CT), subjects will receive 30 to
45 g glucose gel (Gli-Instan, Lightsweet ™) to maintain
levels above 120 mg/dL, and their blood glucose will be
checked again 15 min later. Those with blood glucose
higher than 250 mg/dL will have their urine tested for
the presence of ketones (ComboStik™, Gyung-Nam,
Korea), and they will be allowed to resume exercise only
if test results are negative. Subjects with blood glucose
lower than 100 mg/dL during exercise sessions will have
to discontinue exercising and be offered a snack. Their
blood glucose will be tested again 15 min later, and they
will be allowed to resume exercise only if their test re-
sults are acceptable [48].
Statistical procedures
For data comparison between pre-exercise and post-
exercise and across groups, nonparametric (Spearman’s
correlation (ρ), chi-square test (χ2), and Mann–Whitney
U test), and parametric tests (t-test, analysis of variance
(ANOVA), multivariate analysis of variance (MANOVA),
multivariate linear regression, and canonical discriminant
analysis) will be used depending on the variable studied,
as well as post hoc tests (Duncan and Waller-Duncan -
ANOVA and MANOVA) [49]. The significance level will
be set at 0.05. All statistical analysis will be performed
using SPSS version 22.0.
Ethical issues
The study protocol followed the principles of the Declar-
ation of Helsinki and was approved by the research ethics
committee (Protocol 925.406 by Instituto de Cardiologia
do RS/Fundação Universitária de Cardiologia – Brazil,
dated 22 December 2014 and signed by Dr. Leonardo
Martins Pires). Furthermore, all subjects will read and give
their informed consent for participation in the research
study. All information will be confidential, subjects’ names
will be kept confidential, and data will be collected for aca-
demic purposes only according to Resolution CNS
N1466/12 [50]. If subjects in the RT and CT groups do
not show any improvements of endothelial function (pri-
mary endpoint) or BP levels compared to those in the AT
group, they will be offered the opportunity to practice the
AT protocol after completion of the study to ensure equal
benefits for all subjects.
Discussion
The Study of Endothelial Function Response to Exercise
Training (SEFRET) is a single-site study that will be con-
ducted in the city of Porto Alegre, Brazil. The study will
be conducted in accordance with the principles of Good
Clinical Practice and all requirements established by
ICFUC relevant bodies and collaborators.
The study results are expected to provide evidence of
cardiovascular protective effects of different types of exer-
cise training by modulating endothelial function in individ-
uals with SAH. Knowing the magnitude of improvement of
endothelium-dependent vasodilation by different types of
exercise training can provide scientific evidence to the pre-
scription of exercise programs for vascular protection tar-
geted to hypertensive individuals. An adequate exercise
program can lead to significant changes in cardiovascular
function and promote health benefits and BP control, thus




ABPM: ambulatory blood pressure monitoring; AT: aerobic training;
BMI: body mass index; BP: pressure blood; CT: combined training;
DBP: diastolic blood pressure; ECG: electrocardiogram; eNOS: endothelial
nitric oxide synthase; ESR: erythrocyte sedimentation rate; FMD: flow-mediated
dilation; FUC: Fundação Universitária de Cardiologia; HDL: high-density
cholesterol; HRR: heart rate reserve; IC: Instituto de Cardiologia;
IPAQ: International Physical Activity Questionnaire; LDL: low-density cholesterol;
NO: nitric oxide; PBMN: Peripheral blood mononuclear cells; PBS: phosphate
buffered saline; PCs: Progenitor cells; RBC: red blood cell; RT: resistance training;
Table 5 Intensity, number of sets, repetitions, rest period between
sets, and session duration of resistance training during a 12-week
intervention
Phase I Phase II Phase III
Intensity 60 % 1-RM 70 % 1-RM 80 % 1-RM
Sets 4 4 4
Repetitions 10 to 12 8 to 10 6 to 8
Rest period between sets 60 s 60 s 90 s
Session duration 40 min 40 min 40 min
Exercise duration (weeks) 4 4 4
1-RM, one-repetition maximum strength test
Table 6 Intensity, number of sets, repetitions, rest period between
sets, and session duration of concurrent training during a 12-week
intervention
Phase I Phase II Phase III
Resistance training
Intensity 60 % 1-RM 70 % 1-RM 80 % 1-RM
Sets 2 2 2
Repetitions 10 to 12 8 to 10 6 to 8
Rest period
between sets
60 s 60 s 90 s
Session duration 20 min 20 min 20 min
Aerobic training
Intensity 50 to 65 % HRR 55 to 70 % HRR 60 to 75 % HRR




1-RM, one-repetition maximum strength test; HRR, heart rate reserve
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SAH: systemic arterial hypertension; SBP: systolic blood pressure; WHO: World
Health Organization; 1-RM: one repetition maximum..
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